Summary:
Noticing changes in memory or ability to think clearly can be concerning.
The TRAILBLAZER-ALZ 2 clinical research study is evaluating an investigational drug for memory loss.
Participants must be 60 to 85 years old, have memory loss that has gotten worse over time, and have a study partner willing to attend appointments throughout the study.
Participants May Receive:
✔ Possible compensation for time/travel
✔ Study-related care at no cost to you
✔ No health insurance required